Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / May / Magnesium DR Risk
Retina News Health Economics and Policy

Magnesium & DR Risk

Study suggests low magnesium levels could be linked to increased diabetic retinopathy risk in patients with type 2 diabetes

5/29/2026 2 min read

Share

  • Full Article
  • Summary
  • Listen
  • Report
  • Poll
  • Top Institutions

Clinical Report: Magnesium Levels and Diabetic Retinopathy Risk

Overview

A systematic review and meta-analysis indicates that low serum magnesium levels are significantly associated with diabetic retinopathy (DR) in patients with type 2 diabetes.

Background

Diabetic retinopathy is a leading cause of preventable vision loss, linked to chronic hyperglycemia and microvascular changes. Magnesium, an essential cation involved in numerous enzymatic processes, has been increasingly implicated in the pathophysiology of diabetic complications, including DR.

Data Highlights

Study TypePatients with DRDiabetic Controls
Observational Studies11001132

Key Findings

  • Low serum magnesium levels are significantly associated with diabetic retinopathy in type 2 diabetes patients.
  • Individuals with DR exhibited lower magnesium levels compared to diabetic controls without retinopathy.
  • Patients with proliferative diabetic retinopathy had even lower magnesium levels than those with non-proliferative disease.
  • The association between magnesium deficiency and DR severity suggests a potential dose–response relationship.
  • Magnesium plays a role in retinal homeostasis and may influence oxidative stress and endothelial dysfunction.

Clinical Implications

The observational nature of the evidence necessitates caution in interpreting these findings.

Conclusion

Further investigation into the role of magnesium in diabetic retinopathy is warranted.

Related Resources & Content

  1. Association Between Levels of Magnesium and Diabetic Retinopathy in Diabetic Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis - PMC
  2. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  3. Diabetic Retinopathy Preferred Practice Pattern® - PubMed
  4. European Journal of Preventive Cardiology — Magnesium-rich diet score is inversely associated with incident cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study
  5. Critical Care (Springer) — Rethinking hypomagnesemia: diagnostic thresholds and metabolic implications in critical illness
  6. Retinal Physician — Dietary Nutrients and Diabetic Retinopathy
  7. Critical Care (Springer) — Paradigm shift in hypomagnesemia: a prospective observational study of ionized magnesium in the ICU
  8. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  9. Diabetic Retinopathy Preferred Practice Pattern® - PubMed
  10. Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy | New England Journal of Medicine
  11. Intensive Diabetes Therapy and Ocular Surgery in Type 1 Diabetes | New England Journal of Medicine
  12. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | The BMJ
  13. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 | The BMJ
  14. Association Between Levels of Magnesium and Diabetic Retinopathy in Diabetic Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis - PMC

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: